Glenmark

Teva Pharmaceuticals, Glenmark, Patent settlement, Generics, US Department of Justice

Teva and Glenmark Agree to $255M Settlement with DOJ in Price-Fixing Case

Anika Sharma

Teva and Glenmark Pharmaceuticals, implicated in a price-fixing scheme, are facing substantial penalties and divestiture mandates after reaching a deferred ...